glp-1 news oct 9 2025 In the phase 3 ACHIEVE-1 trial, published in June 2025, the oral small-molecule receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with Perspectives from employers on the
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)











:max_bytes(150000):strip_icc():focal(644x399:646x401)/Ozempic-injection-101822-f89ffa28671841cdb26ddb53f2b48803.jpg)



![Maille Gherkins Original 12/13.5OZ [UNFI #2144186] [ebt] FRUIT LEATHER](https://cdn.shopify.com/s/files/1/0607/3208/0201/files/599482bf-6955-4088-b408-4fcef24dcb06.jpg?v=1725924875)




